Abstract Objective(s): Lung ischemia-reperfusion (IR) injury is a critical clinical condition characterized by oxidative stress, inflammation, and necroptosis, often leading…
Abstract The inflammatory response during acute lung injury and ARDS leads to an overactive immune response, causing further damage and…
Abstract E-cigarette/vaping-associated lung injury (EVALI) is strongly associated with vitamin E acetate and often occurs with concomitant tetrahydrocannabinol (THC) use.…
Abstract Azacitidine, a hypomethylating agent, has caused a paradigm shift in the outcomes of patients with myelodysplastic syndrome (MDS) and…
Abstract Acute lung injury/acute respiratory distress syndrome (ALI/ARDS), triggered by various pathogenic factors inside and outside the lungs, leads to…
Abstract In the summer of 2019, a cluster of cases were observed with users of battery-operated or superheating devices presenting…
Abstract E-cigarette or vaping product use–associated lung injury (EVALI) is a severe pulmonary illness associated with the use of e-cigarettes…
Abstract E-cigarette or vaping use-associated lung injury (EVALI) remains a major concern due to ongoing use of nicotine and/or cannabis-containing…
Abstract Background: e-Cigarette or vaping-induced lung injury (EVALI) causes a spectrum of CT lung injury patterns. Relative frequencies and associations…
Abstract Objective: Rare co-existance of disease or pathology Background: In 2019, the US Centers for Disease Control and Prevention (CDC)…